Correlation Between Alnylam Pharmaceuticals and Cerevel Therapeutics

Can any of the company-specific risk be diversified away by investing in both Alnylam Pharmaceuticals and Cerevel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alnylam Pharmaceuticals and Cerevel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alnylam Pharmaceuticals and Cerevel Therapeutics Holdings, you can compare the effects of market volatilities on Alnylam Pharmaceuticals and Cerevel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alnylam Pharmaceuticals with a short position of Cerevel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alnylam Pharmaceuticals and Cerevel Therapeutics.

Diversification Opportunities for Alnylam Pharmaceuticals and Cerevel Therapeutics

0.0

Correlation Coefficient

Alnylam Pharmaceuticals  Cerevel Therapeutics

Pay attention - limited upside

The 3 months correlation between Alnylam and Cerevel is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Alnylam Pharmaceuticals and Cerevel Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerevel Therapeutics and Alnylam Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alnylam Pharmaceuticals are associated (or correlated) with Cerevel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerevel Therapeutics has no effect on the direction of Alnylam Pharmaceuticals i.e., Alnylam Pharmaceuticals and Cerevel Therapeutics go up and down completely randomly.

Pair Corralation between Alnylam Pharmaceuticals and Cerevel Therapeutics

If you would invest  23,601  in Alnylam Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  3,501  from holding Alnylam Pharmaceuticals or generate 14.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Alnylam Pharmaceuticals  vs.  Cerevel Therapeutics Holdings

Alnylam Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Alnylam Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Alnylam Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Cerevel Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cerevel Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Cerevel Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Alnylam Pharmaceuticals and Cerevel Therapeutics

The main advantage of trading using opposite Alnylam Pharmaceuticals and Cerevel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alnylam Pharmaceuticals position performs unexpectedly, Cerevel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will offset losses from the drop in Cerevel Therapeutics' long position.

The idea behind Alnylam Pharmaceuticals and Cerevel Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.